Watermark Medical Introduces Secure Sleep Study™ to Test Commercial Truck Drivers for Obstructive Sleep Apnea in the Comfort of Their Home or Cab
BOCA RATON, Fla.--(BUSINESS WIRE)-- Watermark Medical, Inc. (“Watermark”), the leader in Health Information Technology for managing chronic diseases, has aligned with the American Academy of Sleep Medicine (AASM) in expanding requirements for board certified doctors on their end to end cloud based platform for diagnosing Obstructive Sleep Apnea (OSA).
In addition, Watermark announced today the commercial availability of WM Secure Sleep Study™ (WM S3). The WM S3 integrates with the ARES™ home sleep test to provide “chain of custody” (CoC) validation to support occupational testing of commercial truck drivers in the comfort of their home or cab. The transportation industry’s growing recognition of the liability, cost and health risk resulting from untreated OSA has caused a call to action to implement more robust screening and testing protocols.
Watermark has aligned the WM S3 with the AASM Standards for Out of Center Sleep Testing Accreditation by requiring users of the WM S3 to have all results interpreted by a board-certified sleep physician. The AASM applauds this requirement as the diagnostic model improves access to the latest medical services for patients with OSA while also ensuring that they receive the highest quality of care from physicians credentialed in sleep medicine.
According to Charles Alvarez, Watermark president and co-founder, “Our goal is to enable the best possible outcome for the millions of patients with OSA at the lowest cost possible. This resonates with everyone in the value chain from patients to payors to physicians.” The alignment of quality care for patients by board certified physicians with streamlined cost is supported by the AASM.
Watermark’s transformative platform enables granularity and transparency for physicians and payors and helps educate them on the advantages of adopting home sleep testing as a part of their clinical offering. To date, Watermark Medical’s platform has produced an eighty percent reduction in “cost to diagnose” through site of service from traditional in-lab polysomnography to home sleep testing and a fifty percent reduction in healthcare spend for employees with undiagnosed OSA.
According to Alvarez, physicians have embraced Watermark’s integrated end to end system because it provides sleep doctors a centralized aggregation of patient data, facilitating additional control and improved patient satisfaction and outcomes.
The utilization of Out of Center Sleep Testing will continue to increase as technology evolves to meet the growing demand for sleep-related diagnostic services. Blue Cross Blue Shield of Florida recently announced that it will now cover Out of Center Sleep Testing, bringing the number of covered lives in the U.S. to more than 225 million.
Watermark Medical, Inc., is a privately held healthcare information technology company focused on improving the clinical outcomes of patients with chronic diseases. Watermark pioneered cloud-based HST for Obstructive Sleep Apnea by allowing primary care physicians to become the point of care for diagnostic testing. Its co-founders are serial entrepreneurs with a track record of building successful information technology companies and sales channels for medical service companies. Information technology management company CA Technologies (NASDAQ: CA) is Watermark’s largest investor. Currently, Watermark has a national direct sales force of more than 30 sales representatives covering all 50 states and approximately 2,000 distribution sales representatives. The company is headquartered in Boca Raton, FL.
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS: Technology Data Management Internet Networks Software Practice Management Health Hospitals Mobile/Wireless Other Health Research Science General Health